Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease-Reference-Cited by-同舟云学术

Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease

Published:2022-08-27 Issue:8 Volume:14 Page:1633-1642
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:
Short-container-title:WJH

Author:

Salgado Alvarez Giovanni Alejandro,Pinto Galvez Samanta Mayanin,Garcia Mora Uriel,Cano Contreras Ana Delfina,Durán Rosas Cristina,Priego-Parra Bryan Adrián,Triana Romero Arturo,Amieva Balmori Mercedes,Roesch Dietlen Federico,Martinez Vazquez Sophia Eugenia,Mendez Guerrero Ines Osvely,Chi-Cervera Luis Alberto,Bernal Reyes Raúl,Martinez Roriguez Leonardo Alberto,Icaza Chavez Maria Eugenia,Remes Troche Jose Maria

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference28 articles.

1. Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

2. Non-alcoholic fatty liver: another feature of the metabolicsyndrome?

3. The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View

4. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

5. Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of sphingolipid metabolism in liver fibrosis;Metabolism and Target Organ Damage;2024-09-14

2. The correlation between liver fibrosis and the 10‐year estimated risk of cardiovascular disease in adults with metabolic‐associated fatty liver disease: A cross‐sectional study in Vietnam;Health Science Reports;2024-05

3. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis;BMC Medicine;2024-03-06

4. Linking Metallic Micronutrients and Toxic Xenobiotics to Atherosclerosis and Fatty Liver Disease—Postmortem ICP-MS Analysis of Selected Human Tissues;Nutrients;2023-08-04

5. Analysis of the Genetic Relationship between Atherosclerosis and Non-Alcoholic Fatty Liver Disease through Biological Interaction Networks;International Journal of Molecular Sciences;2023-02-18